Don't get left behind! The modernized ClinicalTrials.gov is coming. Check it out now.
Say goodbye to ClinicalTrials.gov!
The new site is coming soon - go to the modernized ClinicalTrials.gov
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT01772862
Previous Study | Return to List | Next Study

Rehabilitation Including Social and Physical Activity in Children and Teenagers With Cancer (RESPECT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01772862
Recruitment Status : Unknown
Verified February 2013 by Kjeld Schmiegelow, Rigshospitalet, Denmark.
Recruitment status was:  Recruiting
First Posted : January 21, 2013
Last Update Posted : February 7, 2013
Sponsor:
Collaborators:
Odense University Hospital
Aarhus University Hospital
Aalborg University Hospital
Information provided by (Responsible Party):
Kjeld Schmiegelow, Rigshospitalet, Denmark

Brief Summary:
The purpose of this study is to determine whether early rehabilitation intervention including individualized physical training and social activities with a class mate at two weeks intervals at the ped.onc. center will increase children with cancer's level of physical performance

Condition or disease Intervention/treatment Phase
Childhood Cancer Behavioral: Intervention group Not Applicable

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 240 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: Rehabilitation Including Social and Education in Children and Teenagers With Cancer
Study Start Date : January 2013
Estimated Primary Completion Date : January 2019
Estimated Study Completion Date : January 2019

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
No Intervention: Only conventional supportive care
The children receive conventional supportive care with respect to physical training
Experimental: Intervention group

The intervention components includes (real time sequence):

An educational session where the child is educated on his/her cancer disease. An education session in the child's school where the child´s teachers, classmates and their parents are educated on the child´s cancer disease.

Appointment of two classmates as "ambassadors". An individualized physical training program combining supervised and non-supervised training 3-5 times per week.

Continued specialized physical training when relevant. At two weeks intervals joined education, physical and social activity days at the hospital with together with one of the ambassadors

Behavioral: Intervention group

The intervention components includes (real time sequence):

An educational session where the child is educated on his/her cancer disease. An education session in the child's school where the child´s teachers, classmates and their parents are educated on the child´s cancer disease.

Appointment of two classmates as "ambassadors". An individualized physical training program combining supervised and non-supervised training 3-5 times per week.

Continued specialized physical training when relevant. At two weeks intervals joined education, physical and social activity days at the hospital with together with one of the ambassadors

Other Name: Integrated physical training




Primary Outcome Measures :
  1. Level of VO2 max [ Time Frame: 1 year after cessation of first-line cancer treatment ]
    We hypothesize that the children in the intervention group receiving a individualized physical training program three time a week during the intensive treatment period with surgery, irradiation or chemotherapy treatments will have a 10% higher VO2max level than children with cancer in the control group who do not receive such training


Secondary Outcome Measures :
  1. Health quality of life [ Time Frame: Diagnosis, 6 months after diagnoses, 1 year post treatment ]
    Quality of life is assessed by questionnaires, and qualitative interviews



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   6 Years to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Children diagnosed with cancer and treated at the pediatric oncology units in Denmark (Rigshospitalet, Odense University hospital, Aarhus University Hospital and Aalborg University Hospital)

Children diagnosed with non-malignant diseases treated with surgery, chemotherapy or irradiation similar to cancer (e.g. benign CNS tumors, langerhans cell histiocytosis, Myelodysplastic Syndrome (MDS)) and treated at the pediatric oncology units in Denmark (Rigshospitalet, Odense University hospital, Aarhus University hospital and Aalborg University Hospital).

Attend school at the time of diagnosis

Able to communicate in Danish

Exclusion Criteria:

  • Mental retardation at the time of diagnosis (including Down syndrome) Terminal illness at the time of diagnoses Severe co-morbidity

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01772862


Contacts
Layout table for location contacts
Contact: Kjeld Schmiegelow, M.D 0045 35451357 kjeld.schmiegelow@regionh.dk
Contact: Hanne Larsen, MS Sociology 0045 35459647 hanne@baekgaard.com

Locations
Layout table for location information
Denmark
Kjeld Schmiegelow Recruiting
Copenhagen, Denmark, 2100
Contact: Kejld Schmiegelow, MD    +4535451357    kjeld.schmiegelow@regionh.dk   
Contact: hanne Larsen, post.doc    +4535459647      
Sub-Investigator: hanne Larsen, post.doc         
Sponsors and Collaborators
Kjeld Schmiegelow
Odense University Hospital
Aarhus University Hospital
Aalborg University Hospital
Investigators
Layout table for investigator information
Study Director: Kjeld Schmiegelow, M.D University Hospital of Copenhagen, Rigshospitalet
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Layout table for additonal information
Responsible Party: Kjeld Schmiegelow, Professor, Rigshospitalet, Denmark
ClinicalTrials.gov Identifier: NCT01772862    
Other Study ID Numbers: RESPECT - physical activity
H-3-2012-105 ( Other Identifier: Ethical Review Board of Region Hovedstaden )
First Posted: January 21, 2013    Key Record Dates
Last Update Posted: February 7, 2013
Last Verified: February 2013
Keywords provided by Kjeld Schmiegelow, Rigshospitalet, Denmark:
childhood
cancer
physical activity
quality of life